The normal spinal cord coordinates movement and sensation in the body. It is a complex organ containing nerve cells, supporting cells, and nerve fibers to and from the brain. The spinal cord is arranged in segments, with higher segments controlling movement and sensation in the upper parts of the body and lower segments controlling the lower parts of the body. Recent notable discoveries in the fields of neuroscience and cell biology have ensured that many more people survive injuries to the brain and spinal cord. The consequences of injury reflect this organization. Although these developments have been mirrored by significant strides in our understanding of the evolution and pathology of spinal injuries, complete repair of structure and hence function remain elusive. Most spinal cord injuries still cause lifelong disability, and continued research is critically needed. Here we review the molecular and cellular processes that occur during the evolution of an injury to the central nervous system. Throughout, we highlight several promising therapies aimed to restore the disrupted connections in the brain and spinal cord. These, used in combination with supportive care and rehabilitation strategies, may help patients to achieve significant long-term recovery.
T he promise of finding a treatment that will lead to functional recovery for patients disabled by neurological insults is the motivation behind much of the enormous worldwide research effort in neuroscience. A large portion of that research effort has been directed toward discovering the factors that block nerve regeneration and that inhibit plasticity in the adult central nervous system (CNS). There are many neurological afflictions that involve structural damage to the CNS, but of these spinal cord injury (SCI) has always been regarded as the prototype of lesions in which repair through long-distance regeneration would restore function. For this reason, repair of SCI remains a "holy grail" for neuroscientists. Unfortunately, nerve regeneration is a hugely complex process in which there is a dialogue between the injured axon and its environment involving many different molecular mechanisms. In this article we write about recent advances in the international effort to promote CNS axon regeneration. In particular, we describe the various emerging treatments that have the potential to improve nerve regeneration in injured patients.
It is now clear that there are two main problems that need to be solved, often known as the intrinsic and extrinsic influences on axon regeneration. By extrinsic influences we mean the factors in the tissue surrounding axons that inhibit their regeneration. These factors are mainly associated with the scar tissue that forms where the CNS is injured, and with oligodendrocytes throughout. By intrinsic influences we mean the relatively feeble effort that is made by many CNS axons to regenerate. There are potential treatments that are aimed at all these factors, but there is a general belief that it will be necessary to use several treatments together to achieve the best effects.
THE GLIAL SCAR: A BARRIER TO SPROUTING AXONS
The mature spinal cord relays information to and from the brain through an intricate net of neurons interconnected by processes, through which the action potentials travel. Surrounding these neurons is a mesh of glial cells, in a histological organization of almost crystalline regularity. 1 An order of magnitude more profuse than neurons, these glial cells provide the structural and biochemical environment that is essential for proper neuronal function. Human spinal cord injury usually begins with a sudden, traumatic blow to the spine that fractures or dislocates vertebrae. At the moment of impact, displaced bone fragments, disk material, and ligaments smash into spinal cord tissue breaching the neural cell membranes and producing partial, rarely complete transections. This immediate physical disruption of axons, neurons, and glia is merely the beginning of the devastation that ensues over the coming days. The trauma triggers a prolonged period of secondary damage during which inflammation, metabolic disturbance, and other aftereffects of injury cause further axon damage, cell death, and demyelination 2 (Fig. 1 ). During this period there are important reactive changes in the morphology and function of the glial cells. 3 At the site of the lesion both neuronal and glial cells undergo cell death resulting in the formation of a cavity. Nearby glial cells respond by proliferating and migrating, reorganizing the tissue architecture to form a "glial scar," comprising of a tightly interwoven meshwork of glial cells, mesenchymal cells, and modified extracellular matrix. 4 Formation of the scar is a dynamic process that evolves over many days after the injury. A few hours after injury, macrophages from the bloodstream and microglia (specialized macrophages) migrate inward to the injury site from the surrounding tissue; 3 to 5 days later large numbers of oligodendrocyte precursors (specialized stem cells found throughout the CNS) proliferate and populate the area. If the injury breaches the meningeal layer covering the CNS, the meningeal cells rapidly divide and migrate into the injured parenchyma to form a central plug of collagenous tissue. 5 At approximately 10 days after injury, the final structure of the glial scar is formed. The eventual area of destruction and scarring often involves several segments of the cord, and hence the functional deficit may be considerable.
The mechanisms that lead to the formation of the glial scar are becoming more apparent. The starting point may be when CNS injury punctures the blood-brain barrier, allowing serum components into the CNS parenchyma. It is this initial leakage of molecules, notably free radicals, chemokines (MCP-1) and complement normally excluded from the neuronal microenvironment, together with macrophage activation that is considered to be the principal trigger. Increased expression of glial fibrillary protein (GFAP) at, and some distance beyond, the injury site stimulates the astrocytes into a reactive state. 6 In the normal CNS, tight junctions are found between the astrocytic processes of the glia limitans, but after damage many of the astrocytes throughout the scar region are bound together by tight junctions. This may have the effect of making the tissue mechanically strong, but may also make it harder for axons and migrating cells to pass through it. Because astrocytes are also key regulators of the chemical environment of the CNS, reactive astrocytosis can lead to a myriad of changes. For inhibiting glial scarring it is important to identify some of the key molecules that cause it, and it appears that transforming growth factor β1/2, 7 interleukin-1, 8 and IFNγ 9 are major players.
Since the pioneering studies of Tello 10 and Ramón y Cajal 11 it has become well established that the glial scar forms a major impediment to axon regeneration. Their revolutionary observation was that some CNS axons were able to regrow, but stopped when confronted with the glial scar at the site of the lesion. Here the axon tips collapsed and retracted. 12 However, it should be noted that the glial scar is not completely detrimental; although it has an undesirable effect on axon regeneration it also reconstitutes the blood-brain barrier after injury-induced disruption, stabilizing the biochemical environment and isolating the preserved nervous system from an otherwise overwhelming inflammatory response. 13, 14 In the last decades, the glial scar has been the focus of attention of many researchers, and progress has been achieved in the understanding of the physical, molecular, and cellular composition responsible for its inhibitory nature. Three active participants in the failure of axon regeneration are the ephrins, semaphorins, and proteoglycans.
INHIBITION IN THE GLIAL SCAR Ephrins
Ephrins are a family of membrane proteins that are important in axon pathfinding and target recognition during CNS development, where they act as chemorepellent signals for axon growth, 15 maintainers of cellular organization, 16 or regulators of cell adhesion and cell migration. 17 They are subdivided into ephrin-A and ephrin-B families depending on the nature of their linkage Figure 1 . The main obstacles to nerve regeneration are the low ability of central nervous system neurons to elongate their axons, due to the reduced expression of growth promoting proteins such as GAP-43, the reduced formation of secondary messengers at the growth cones, and the lack of trophic support from the neighboring glial cells. Formation of a glial scar acts as a physical (astrocyte hyperplasia and hypertrophy) and biochemical barrier (proteoglycans and semaphorins) to axon growth. Any successful axons able to traverse this scar will be surrounded ultimately by an inhibitory environment caudal to the injury composed of repulsive molecules expressed by oligodendrocytes.
to the plasma membrane. There they can bind to their receptors, the Eph tyrosine kinases, which can also be linked to the cell surface, and signaling can occur from both. 18, 19 Interactions of ephrins with their respective receptors induce growth cone collapse through the activation of a signaling pathway that includes RhoA, together with the simultaneous downregulation of the similar molecules Cdc42 and Rac1. 20 Increased levels of ephrins and their receptors are seen following spinal cord injury. Miranda and collaborators demonstrated that astrocytes in the white matter of the contusion site increased the expression of the Eph B3 receptor. 21 Bundesen and collaborators showed a coordinated expression of ephrins in astrocytes and infiltrating meningeal fibroblasts at the site of injury. 22 These observations lead to the idea that ephrins might be one of the factors that inhibit axon regeneration. The best evidence for this at present comes from Eph4 knockout mice, in which Goldshmit and collaborators 23 observed a reduced glial scar together with increased axon regeneration after a spinal cord hemisection.
Semaphorins
Semaphorins are a large family of membrane-associated and secreted proteins. 24 Of these, the best characterized is Sema3A. During development, semaphorins are involved in axon guidance, axon steering, fasciculation, branching, and synapse formation. They can act as axon attractants or repellants by binding to the neuropilin-plexin receptor complex. 25 Semaphorin 3A (Sema3A) is not only expressed during CNS development, but it is also present in the adult brain and spinal cord, mainly in the olfactory and motor systems. 26 In the spinal cord Sema3A is expressed in the motoneurons, 27 whereas the receptor complex is located in the descending corticospinal and rubrospinal tracts 28 and in the nociceptive sensory peripheral axons. 29 Because some axons have neuropilin on their surface it has been suggested that Sema3A may prevent sprouting in the normal adult spinal cord. 30 Following injury to the spinal cord there is an upregulation of the expression of both secreted and membrane-attached Sema3A, mainly in the meningeal fibroblasts that invade the core of the wound. Axons hardly ever grow into these semaphorinrich regions, suggesting that semaphorins contribute to the inhibitory nature of the glial scar. 28 At present there is no treatment to block this inhibitory mechanism.
Proteoglycans
The third family of inhibitory molecules in the glial scar is the proteoglycans (PGs). There are several families of these that share a common molecular structure, a central core protein with a number of sulfated sugar chains known as glycosaminoglycan (GAG) chains. Depending on the type of sugars, PGs can be classified as heparan sulfate proteoglycans, chondroitin sulfate proteoglycans (CSPGs), dermatan sulfate proteoglycans, or keratan sulfate proteoglycans. PGs can be secreted to the extracellular matrix, be attached to the cell membrane, or be transmembrane. While the GAG chains have a substantial degree of conformational flexibility, PGs have a tendency to draw large amounts of water in to form gels. This structure, alongside protein/GAG interactions, allows PGs to perform a diverse array of functions; cell adhesion, growth, or barrier formation and interaction with other extracellular matrix molecules. [31] [32] [33] [34] [35] [36] [37] Although several mechanisms have been proposed for the inhibitory activity of proteoglycans, their precise mode of action is not understood. Their binding properties depend on the pattern of negative charges associated with the sulfated GAG chains, and if this sulfation is prevented the molecules lose much of their inhibition. 38, 39 CSPGs are considered to bind inhibitory proteins such as semaphoring and NOGO. It is possible that the CSPG play a direct role in the inhibitory mechanisms of these proteins. The molecules have been shown to induce an increase of intracellular calcium in the neuronal growth cone, 40 mask growth-promoting molecules, 41 reduce adhesion, 42 cause stearic hindrance, 43 and present various inhibitory molecules. 44 CSPGs (aggrecan, versican, neurocan, brevican, neuroglycan D, NG2, the receptor-type protein tyrosine phosphatase RPTPb and its splice variant phosphacan) are the most prevalent of all the PGs expressed in the mammalian CNS, produced by astrocytes, oligodendrocyte precursors, and meningeal cells after an injury. Several recent studies have shown that CSPGs halt axonal growth, and recently detailed descriptions of the time course of their expression following injury 45, 46 have brought PGs into the limelight, establishing them as one of the most important inhibitory molecules expressed by the injured CNS.
MODIFICATION OF THE GLIAL SCAR
Scar formation blocks axon regeneration, so several methods have been developed to modify it. Simply killing cells in the scar, with topical injection of ethidium bromide, 47 cell cycle mitogenic toxins, 48 and X-ray irradiation 49, 50 has led to some axon regeneration, but these methods are not suitable for clinical practice. More selective techniques to create a glial-free environment permissive to axon outgrowth include the use of the toxin L-α-amino adipate, which specifically kills astrocytes. 51 Grafting in other types of glial cells can reduce the "reactivity state" of the astrocytes. Olfactory Spinal Cord Repair ensheathing cells have been reported to modify astrocyte reactivity when grafted into the lesion site. 52 Data suggest that these grafts have persuaded corticospinal axons to regenerate after an injury, in some cases with significant amounts of functional recovery. 53 Another inhibitory feature of glial scars is the formation of a collagenous membrane across lesions, which regenerating axons seldom cross. Stichel and collaborators 54 showed that the application of the iron chelator 2′2′-dypiridine (DPY), which inhibits the synthesis and formation of collagen fibers, reduced the deposition of collagen at the glial scar, and permitted the regeneration of axons in the brain and spinal cord. 55 Because chondroitin sulfate proteoglycans are a major source of inhibition, an approach that has produced promising results is the application of chondroitinase ABC to the damaged neural tissue. This enzyme splits the glucosidic bonds between two adjacent sugar monomers of GAG chains in chondroitin sulfate and dermatan proteoglycans, 56 leading to the digestion of GAG chains into disaccharides, which diffuse away. Application of chondroitinase ABC to a variety of injury paradigms has resulted in marked improvements in axon regeneration across the injury site and considerable recovery in animal behavior. Bradbury and colleagues demonstrated that local infusion of chondroitinase ABC enhanced the regeneration of corticospinal axons as well as improved behavioral tasks after a cervical dorsal column crush. 57 Gross locomotion improvement was also achieved in animals with a moderate contusion, 58 and in animals with complete transection of the thoracic spinal cord. Fouad and collaborators 59 modified this approach in a combined intervention strategy. Using polymer bridges filled with Schwann cells (myelinating cells of the peripheral nervous system), transplantating olfactory ensheathing cells and infusing chondroitinase ABC at the proximal and distal stumps of the spinal cord, they observed regrowth of serotonergic axons in the lumbar spinal cord and partial locomotor recovery of the animals treated. Chondroitinase treatment has also been successful in persuading regenerating axons to grow through grafts of peripheral nerve inserted into the spinal cord to provide axons with a permissive conduit for growth. 60, 61 
OLIGODENDROCYTES AND INHIBITION
Oligodendrocytes in vitro and myelin extracts are spectacularly inhibitory to axon regeneration. By fractionating myelin, Caroni and Schwab 62 identified a myelin inhibitory molecule, now known to be NogoA. This is found on oligodendrocytes and on some axons, and interacts with the Nogo66 receptor and with another unidentified receptor. There are now several antibodies that partly block the regeneration inhibitory action of NogoA, and these promote axon regeneration in rodent spinal cord and functional recovery after spinal injury and stroke. [63] [64] [65] These observations were followed by immunization of lesioned animals with CNS myelin, lysation of myelin with antibody and complement in vivo, or enhancement of myelin clearance by injecting activated macrophages. [66] [67] [68] The discovery that the NogoA receptor exhibits neural specificity and is also a high-affinity receptor for other known myelin inhibitory proteins (MAG and OMgp) [69] [70] [71] could be a reason for the devastating suppression of neuronal growth by CNS myelin after spinal cord injury. A humanized anti-NogoA antibody has just entered clinical trials, and there are great hopes that this will be the first really effective agent for treating humans with spinal cord injury.
AXONAL INTRINSIC REGENERATIVE ABILITY
Although the glial environment undoubtedly governs the regenerative capabilities of axons, axons are not merely passive bystanders. Much of the failure of regeneration can be ascribed to the intrinsic nature of the axon itself. Several axonal properties affect regeneration: embryonic axons usually regenerate better than adult, axons regenerate better when cut near the cell body, and there are considerable differences in regenerative ability between different types of neuron.
Neuronal Age
Embryonic rodent retinal neurons extend axons on sections of both embryonic and adult optic nerve; this is a response that declines with neuronal maturation. 72, 73 Similarly, adult neurons are unable to extend processes into 3-dimensional cultures of astrocytes, although profuse axonal growth is seen from embryonic neurons. 74 The issue of whether the neuron or the environment blocks regeneration can be investigated by putting together tissues of different age in culture, for instance, old neurons with embryonic environment and vice versa. In retinal explants, hippocampal slices, and following transplantation of embryonic neurons into the adult brain, [75] [76] [77] [78] [79] the results indicate that it is the age of the neuron that matters, and adult neurons regenerate their axons poorly even when provided with an "immature" environment in which to regenerate.
The molecular basis of this age "switch," understandably of great interest, could be due to changes in the internal machinery for axon growth, 80 or in the molecules by which axons interact with their environment, in particular, adhesion molecules mediating cell-cell interactions and receptors for components of the extracellular matrix (ECM). Both types of change have been seen. On the axon surface integrins modulate the growth of axons on ECM molecules. Embryonic axons can adapt their cell surface integrins to suit their environment, but adult axons cannot. 81 Inside the axons there are many differences between embryonic and adult axons that may be significant, for instance, the expression of growth-associated molecules within axons. Growthassociated protein-43 (GAP-43) present in all growth cones during development is only expressed in regenerating axons. 82, 83 Similarly, embryonic forms of several microtubule-associated proteins (MAPs), stabilizers of the axonal cytoskeleton, 84 are not re-expressed during regeneration. 85 Growth factors can also greatly increase the vigor of regeneration; yet their receptors are downregulated in many mature axons and may not return during regeneration. Although adult axons are critically dependent on the presence of autocrine survival factors, it appears that embryonic axons do not require such support, which may explain their more robust regeneration in hostile surroundings.
Role of the Distance Between Injury and Neuronal Cell Body
In terms of both initial axonal degeneration and subsequent regeneration, the closer the site of transection to the cell body, the more robust the regenerative response of CNS neurons. 86 The pioneering experiment of David and Aguayo, 87 placing peripheral nerve grafts into the spinal cord, demonstrated that only axons cut near their cell bodies regenerated into this growth-promoting region. This poses a major problem for neuronal repair, because many of the vital axonal pathways that need to be repaired are long, for example, the corticospinal and rubrospinal tracts. There has been considerable interest, therefore, in finding methods to induce regeneration in axons severed far from the cell body.
One particularly well-studied pathway is the rat rubrospinal tract, whose axons will regenerate into peripheral nerve grafts placed in the cervical spinal cord, but will not regenerate into the permissive environment of a peripheral nerve graft if it is placed about a centimeter further from the cell body in the thoracic cord. However, if the neurons are stimulated by applying trophic factors to the cell bodies, their regenerative ability can be increased. The trophic factors that are most effective in the rubrospinal tract are brain-derived neurotrophic factor (BDNF) and ciliary-derived neurotrophic factor (CNTF), although other tracts are stimulated to regenerate by neurotrophin-3 (NT-3), glial cell line-derived neurotrophic factor (GDNF), and other factors. Infusions of these trophic factors, whether around the neurons or around the axons, reduce the atrophy of the axons after axotomy, upregulate the expression of GAP-43 by the cell body, 88, 89 and restore the ability of the neurons to regenerate their axons when axotomized further from the cell body. 82 To date, this treatment has been the most effective treatment and there are now several examples where it has been used with success in vivo. 90, 91 Neuronal Cell Type Variability Different neuronal types, even when presented with a favorable environment (peripheral nerve graft) vary greatly in their ability to regenerate. Perhaps the most extreme example of this selective regeneration is the Purkinje cells of the cerebellum whose axons never regenerate. Indeed, when peripheral Schwann cells or embryonic CNS grafts are placed into the cerebellum, 92 Purkinje and granule cells never regenerate axons despite that their cell bodies are optimally placed to respond. However, the climbing fibers regenerate profusely into precisely the same environment. Similarly, peripheral nerve grafting into the thalamus results in axotomy of the thalamocortical projection neurons, corticothalmic projection neurons, and neurons of the thalamic reticular nucleus (TRN). By far, the majority (~80%) of the regenerating axons originate from the TRN, 93 despite representing only a small proportion within the thalamus. Other notable examples include corpus striatal grafts, where regenerating sprouts derive from neurons in the substantia nigra pars compacta and minimal regeneration is observed from the corticospinal projections or neostriatal neurons that also extend through this region, 94 and corticospinal tract (CST) axons, which fail to regenerate into peripheral grafts in the spinal cord or brainstem. [95] [96] [97] [98] [99] [100] At the other extreme are spinal motor neurons. These axons are probably the best axons in the CNS at regenerating, especially when cut close to the cell body. These axons have been used as the basis of a technique for repairing injuries where the central roots are avulsed from the cord: peripheral nerve tissue is reimplanted into the cord, and the motor axons regenerate into it.
ROLE OF THE INTRINSIC NEURONAL STATE
The importance of the intrinsic state of the neuron in regeneration is becoming increasingly recognized. In particular, the response of a neuron to environmental cues may be highly affected by cytosolic cyclic nucleotide levels. Growth cones of Xenopus spinal neurons are usually attracted to a source of netrin-1 or BDNF, but this response is reversed by the addition of a cAMP antagonist or the protein kinase A (PKA) inhibitor. 101 Similarly, the repulsive effects of both semaphorin III and myelinassociated glycoprotein (MAG) can be converted to attraction by the activation of cGMP and cAMP, respectively. 102 Of particular importance in terms of CNS regeneration is the finding that pretreatment of neurons with neurotrophins ("priming") can allow them to overcome the inhibitory properties of MAG, 103 an effect that appears to be mediated by an increase in intracellular levels of cAMP. This mechanism may explain the beneficial effects of NT-3 treatment on corticospinal tract regeneration in vivo 104, 105 and the increased optic nerve regeneration that follows the transplantation of segments of peripheral nerve into the eye. 106 An alteration in the intrinsic state of the neuron also helps to explain how a "conditioning lesion" of the peripheral branch of the dorsal root ganglion leads to improved axonal regeneration of central projections into the dorsal columns of the spinal cord. 107, 108 Qiu et al reported that this conditioninglesion effect manifests itself via a cAMP mechanism such that neuronal levels of cAMP increase after the first axotomy. 109 
CONCLUSION
The tremendously fast pace of progress in our understanding of growth cone biology, the identification of axon growth inhibitors and their receptors in the adult mammalian CNS, and elucidation of their mechanisms of action offer great promise for the development of therapeutic strategies to promote axon regeneration in the injured CNS. Enthusiasm, however, must be tempered with caution due to the complexity of the injury response and the simultaneous involvement of multiple neuronal pathways. One issue that has become clear with regard to functional recovery after CNS injuries such as spinal cord damage is that experimental treatments to disrupt the postinjury inhibitory environment or to modify the internal components of axons can lead to sprouting from undamaged fibers of the same fiber pathway or other fiber pathways. Crucially, these can result in innervation of denervated targets and restoration of function. It is possible that motor connections that are functionally inappropriate under these conditions could then be pruned with appropriate feedback and rehabilitation. This type of growth and plasticity in the motor system could therefore be fostered to promote motor recovery. Equally though, such sprouting in sensory systems could lead to the generation of debilitating intractable pain and parethesias. This issue must be carefully addressed if we are to effectively exploit these potential therapies.
